Ian Y. serves as the Director and Co-Founder of Orientime Capital, Inc., a Vancouver-based venture capital firm focused on supporting small to medium-sized enterprises in impactful sectors such as HealthTech and FinTech since June 2021. In addition to this role, Ian holds multiple positions on various boards, including the Manufacturing Safety Alliance of BC and the Mid-Main Community Health Centre. Additionally, Ian contributes as a Venture Scout at several venture capital firms, such as Beyond Capital, Exitfund, Climate Capital, Earthshot Ventures, and 7BC Venture Capital, alongside being an Investor in the Spring Investing Collective. Ian's extensive educational background includes a Master of Finance from the University of Toronto's Rotman School of Management and previous degrees from UBC, Queen's University, and Shenzhen University.
This person is not in any teams
Gene Bio Medical (Gene Biotechnology Enterprises Ltd.)
Gene Bio Medical is dedicated to the research & development, manufacturing, and commercialization of high-precision, low-cost, and effective diagnostic technologies that improve human health and enable the response capabilities towards a variety of diseases. We have a vision to revolutionize the healthcare industry and innovate for the greatness of our community. Founded by a group of talented research scientists, practitioners, and business experts, Gene Bio Medical has rapidly developed into an industry leader in molecular diagnostics technologies. The company manufactures and markets its own products, develops new innovative products, and collaborates with the healthcare ecosystem to bring innovations to people.